Robert Besser
04 Dec 2022, 08:04 GMT+10
WASHINGTON D.C.: According to trial data contained in a report presented this week, an experimental Alzheimer's drug from Eisai and Biogen, lecanemab, slowed cognitive decline, but could cause serious side effects for certain patients.
In the 18-month trial involving nearly 1,800 participants with early-stage Alzheimer's, Lecanemab was possibly the cause of a dangerous type of brain swelling in nearly 13 percent of patients.
Five patients also suffered from macrohemorrhages and 14 percent from microhemorrhages, which could have caused two deaths in a follow-on study.
In September, the two companies said that lecanemab, an antibody designed to remove sticky deposits of a protein called amyloid beta, reduced the rate of cognitive decline on a clinical dementia scale (CDR-SB) by 27 percent, compared to a placebo.
However, Dr. Ronald Petersen of the Mayo Clinic in Rochester, Minnesota said, "All of these amyloid-lowering drugs carry a risk for increased brain hemorrhage."
The data confirms the drug "can meaningfully change the course of the disease," said the Alzheimer's Association, calling on U.S. regulators to approve the company's application for accelerated approval.
Detailed data from the study was presented at the Clinical Trials on Alzheimer's Disease meeting in San Francisco.
The U.S. Food and Drug Administration (FDA) will decide whether to approve lecanemab under its "accelerated" review program by 6th January. However, Eisai will soon file for standard FDA approval of the drug and will also seek approval in Europe and Japan, regardless of the FDA's decision.
Get a daily dose of Madagascar Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Madagascar Sun.
More InformationOUAGADOUGOU, Burkina Faso: As Burkina Faso, in western Africa, faces an Islamist insurgency, it is set to end a military ...
New Delhi [India], January 30 (ANI): The Indian cricketing fraternity took to social media on Sunday after Team India made ...
Tunis - Tunisia looked set for an ultra-low election turnout again Sunday as a parliamentary election ended with critics of ...
Johannesburg - Coal-rich but energy-starved South Africa will not immediately abandon its fossil-fueled electricity generating plants as it transitions to ...
Potchefstroom [South Africa], January 29 (ANI): India put up a terrific display in the final against England to emerge as ...
Geneva - Ahead of World Neglected Tropical Diseases Day Monday, the World Health Organization is calling for action to tackle ...
NEW YORK CITY, New York: After being convicted of stealing more than $900,000 from the company, Rosita Joseph, former executive ...
WASHINGTON D.C.: The US State Department has said that in the latest fiscal year, US military equipment exported to foreign ...
MACAU CITY, Macau: Over the Lunar New Year holiday, Macau, the world's largest gambling hub, witnessed a resurgence of tourists ...
WASHINGTON D.C.: Republican US Senator Josh Hawley has said that he plans to introduce a bill to ban the use ...
WASHINGTON D.C.: This week, the US Food and Drug Administration (FDA) proposed significant limits on levels of lead in processed ...
WASHINGTON, D.C.: Finland and Sweden are prepared to join the NATO alliance, the U.S. State Department announced this week.The move ...